The Adverse Long-Term Impact of Renal Impairment in Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stent Era | Zendy

Clare Appleby | Zendy; Joan Ivanov | Zendy; Shahar Lavi | Zendy; Karen Mackie | Zendy; Eric Horlick | Zendy; Douglas Ing | Zendy; Christopher B. Overgaard | Zendy; Peter H. Seidelin | Zendy; Rüdiger von Harsdorf | Zendy; Vladimír Džavík | Zendy

Open Access

The Adverse Long-Term Impact of Renal Impairment in Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stent Era

Author(s) -

Clare Appleby,

Joan Ivanov,

Shahar Lavi,

Karen Mackie,

Eric Horlick,

Douglas Ing,

Christopher B. Overgaard,

Peter H. Seidelin,

Rüdiger von Harsdorf,

Vladimír Džavík

Publication year - 2009

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.108.828954

Subject(s) - medicine , mace , percutaneous coronary intervention , hazard ratio , kidney disease , proportional hazards model , renal function , cardiology , drug eluting stent , creatinine , myocardial infarction , confidence interval

An observational study determining the long-term impact of chronic kidney disease (CKD) on patients undergoing percutaneous coronary intervention at a tertiary cardiac referral center. CKD is associated with poor in-hospital outcomes after percutaneous coronary intervention, but its effect beyond 1 year, particularly in the drug-eluting stent (DES) era, has not been reported.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research